SLAS Technology最新文献

筛选
英文 中文
Continuous glucose data construction and risk assessment application of diabetic retinopathy complications for patients with type 2 diabetes mellitus 2 型糖尿病患者连续血糖数据构建及糖尿病视网膜病变并发症风险评估应用。
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-11-13 DOI: 10.1016/j.slast.2024.100221
Yaguang Zhang , Liansheng Liu , Hong Qiao
{"title":"Continuous glucose data construction and risk assessment application of diabetic retinopathy complications for patients with type 2 diabetes mellitus","authors":"Yaguang Zhang ,&nbsp;Liansheng Liu ,&nbsp;Hong Qiao","doi":"10.1016/j.slast.2024.100221","DOIUrl":"10.1016/j.slast.2024.100221","url":null,"abstract":"<div><div>Managing diabetes mellitus (DM) includes achieving acceptable blood glucose levels and minimizing the risk of complications from DM. The appropriate glucose sensing method is continuous glucose monitoring (CGM). Effective evaluation metrics that reflect glucose fluctuations can be realized. However, compared with self-monitoring of blood glucose (SMBG), CGM data are not easy to obtain. Therefore, this article studies a fusion model to achieve this objective, including Gaussian process regression (GPR) and long short-term memory (LSTM). Compared with the three commonly used LSTM, GPR, and support vector machine, the proposed model can construct accurate results. By using the constructed CGM data, the conventional metrics, such as the mean amplitude of glycemic excursion (MAGE), mean blood glucose (MBG), standard deviation (SD), and time in range (TIR), are calculated. These metrics and other variables are input into statistical methods to realize diabetic retinopathy risk assessment. In this way, the relationship between the glycemic variability of the constructed CGM data by the mathematical model and DR could be achieved. The utilized statistical methods include single-factor analysis and binary multivariate logistic regression analysis. Results show that fasting blood glucose, disease course, history of hypertension, MAGE and TIR are independent risk factors for DR.</div></div>","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100221"},"PeriodicalIF":2.5,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Melanoma-on-a-chip model for anticancer drug injecting delivery method 用于抗癌药物注射给药方法的芯片上黑色素瘤模型。
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-11-12 DOI: 10.1016/j.slast.2024.100219
Pedro Herreros , Ana López-Hernández , Miguel Holgado , María Fe Laguna Heras
{"title":"Melanoma-on-a-chip model for anticancer drug injecting delivery method","authors":"Pedro Herreros ,&nbsp;Ana López-Hernández ,&nbsp;Miguel Holgado ,&nbsp;María Fe Laguna Heras","doi":"10.1016/j.slast.2024.100219","DOIUrl":"10.1016/j.slast.2024.100219","url":null,"abstract":"<div><div>The pharmaceutical and cosmetic industries are encountering a challenge in adopting new study models for product development. there has been a growing interest in organ-on-a-chip systems, and particularly for generating skin models. While numerous alternatives replicating high-fidelity skin models exist, there is a notable absence of melanoma study's methodology specifically on these microfluidic chips. This work introduces a novel skin-on-a-chip device featuring two microfluidic chambers, facilitating a 3D cell co-culture involving fibroblasts, keratinocytes, and melanoma cells. The design of this organ-on-a-chip has enabled the administration of the anticancer treatment Gemcitabine using an injection system within the chip. The results of this work have shown a significant impact on the co-culture distribution of cells, decreasing the population of cancerous cells after the administration of Gemcitabine. The work presented in this article demonstrates the effectiveness of the chip and the administration method for testing anti-melanoma therapies and position this technology as an enhanced fidelity model for studying melanoma while providing an alternative for real-time monitoring of drug testing.</div></div>","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100219"},"PeriodicalIF":2.5,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging trends in application of magnetic beads in biopharma industry 生物制药行业应用磁珠的新趋势。
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-11-10 DOI: 10.1016/j.slast.2024.100224
Jianli Zhao
{"title":"Emerging trends in application of magnetic beads in biopharma industry","authors":"Jianli Zhao","doi":"10.1016/j.slast.2024.100224","DOIUrl":"10.1016/j.slast.2024.100224","url":null,"abstract":"","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100224"},"PeriodicalIF":2.5,"publicationDate":"2024-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel multi-omics approach for identifying key genes in intervertebral disc degeneration 识别椎间盘退变关键基因的新型多指标方法
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-11-09 DOI: 10.1016/j.slast.2024.100223
Xuan Zhao , Qijun Wang , Shuaikang Wang , Wei Wang , Xiaolong Chen , Shibao Lu
{"title":"A novel multi-omics approach for identifying key genes in intervertebral disc degeneration","authors":"Xuan Zhao ,&nbsp;Qijun Wang ,&nbsp;Shuaikang Wang ,&nbsp;Wei Wang ,&nbsp;Xiaolong Chen ,&nbsp;Shibao Lu","doi":"10.1016/j.slast.2024.100223","DOIUrl":"10.1016/j.slast.2024.100223","url":null,"abstract":"<div><div>Many different cell types and complex molecular pathways are involved in intervertebral disc degeneration (IDD). We used a multi-omics approach combining single-cell RNA sequencing (scRNA-seq), differential gene expression analysis, and Mendelian randomization (MR) to clarify the underlying genetic architecture of IDD. We identified 1,164 differentially expressed genes (DEGs) across four important cell types associated with IDD using publicly available single-cell datasets. A thorough gene network analysis identified 122 genes that may be connected to programmed cell death (PCD), a crucial route in the etiology of IDD. SLC40A1, PTGS2, and GABARAPL1 have been identified as noteworthy regulatory genes that may impede the advancement of IDD. Furthermore, distinct cellular subpopulations and dynamic gene expression patterns were revealed by functional enrichment analysis and pseudo-temporal ordering of chondrocytes. Our results highlight the therapeutic potential of GABARAPL1, PTGS2, and SLC40A1 targeting in the treatment of IDD.</div></div>","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100223"},"PeriodicalIF":2.5,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning model for early prediction of survival in gallbladder adenocarcinoma: A comparison study 用于早期预测胆囊腺癌生存率的机器学习模型:对比研究
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-11-09 DOI: 10.1016/j.slast.2024.100220
Weijia Wang , Xin Li , Haiyuan Yu , Fangxuan Li , Guohua Chen
{"title":"Machine learning model for early prediction of survival in gallbladder adenocarcinoma: A comparison study","authors":"Weijia Wang ,&nbsp;Xin Li ,&nbsp;Haiyuan Yu ,&nbsp;Fangxuan Li ,&nbsp;Guohua Chen","doi":"10.1016/j.slast.2024.100220","DOIUrl":"10.1016/j.slast.2024.100220","url":null,"abstract":"<div><div>The prognosis for gallbladder adenocarcinoma (GBAC), a highly malignant cancer, is not good. In order to facilitate individualized risk stratification and improve clinical decision-making, this study set out to create and validate a machine learning model that could accurately predict early survival outcomes in GBAC patients. Five models—RSF, Cox regression, GBM, XGBoost, and Deepsurv—were compared using data from the SEER database (2010–2020). The dataset was divided into training (70 %) and validation (30 %) sets, and the C-index, ROC curves, calibration curves, and decision curve analysis (DCA) were used to assess the model's performance. At 1, 2, and 3-year survival intervals, the RSF model performed better than the others in terms of calibration, discrimination, and clinical net benefit. The most important predictor of survival, according to SHAP analysis, is AJCC stage. Patients were divided into high, medium, and low-risk groups according to RSF-derived risk scores, which revealed notable variations in survival results. These results demonstrate the RSF model's potential as an early survival prediction tool for GBAC patients, which could enhance individualized treatment and decision-making.</div></div>","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100220"},"PeriodicalIF":2.5,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of experimental workflows in robotic cultivation platforms 机器人培养平台的实验工作流程管理。
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-10-30 DOI: 10.1016/j.slast.2024.100214
Lucas Kaspersetz , Britta Englert , Fabian Krah , Ernesto C. Martinez , Peter Neubauer , M. Nicolas Cruz Bournazou
{"title":"Management of experimental workflows in robotic cultivation platforms","authors":"Lucas Kaspersetz ,&nbsp;Britta Englert ,&nbsp;Fabian Krah ,&nbsp;Ernesto C. Martinez ,&nbsp;Peter Neubauer ,&nbsp;M. Nicolas Cruz Bournazou","doi":"10.1016/j.slast.2024.100214","DOIUrl":"10.1016/j.slast.2024.100214","url":null,"abstract":"<div><div>In the last decades, robotic cultivation facilities combined with automated execution of workflows have drastically increased the speed of research in biotechnology. In this work, we present the design and deployment of a digital infrastructure for robotic cultivation platforms. We implement a Workflow Management System, using Directed Acyclic Graphs, based on the open-source platform Apache Airflow to increase traceability and the automated execution of experiments. We demonstrate the integration and automation of experimental workflows in a laboratory environment with a heterogeneous device landscape including liquid handling stations, parallel cultivation systems, and mobile robots. The feasibility of our approach is assessed in parallel <em>E. coli</em> fed-batch cultivations with glucose oscillations in which different elastin-like proteins are produced. We show that the use of workflow management systems in robotic cultivation platforms increases automation, robustness and traceability of experimental data.</div></div>","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100214"},"PeriodicalIF":2.5,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of conjugated polymer nanocomposite materials as biosensors in rehabilitation of ankle joint injuries in martial arts sports 共轭聚合物纳米复合材料作为生物传感器在武术运动踝关节损伤康复中的应用。
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-10-29 DOI: 10.1016/j.slast.2024.100213
Yuan Zheng , Xiaoxiao Ren , Linzhen Li
{"title":"Application of conjugated polymer nanocomposite materials as biosensors in rehabilitation of ankle joint injuries in martial arts sports","authors":"Yuan Zheng ,&nbsp;Xiaoxiao Ren ,&nbsp;Linzhen Li","doi":"10.1016/j.slast.2024.100213","DOIUrl":"10.1016/j.slast.2024.100213","url":null,"abstract":"<div><div>In order to understand the application of conjugated polymer nanocomposites as biosensors in the rehabilitation of ankle joint injuries in martial arts, the author proposes a study on the application of conjugated polymer nanocomposites in the rehabilitation of ankle joint injuries in martial arts. Firstly, in martial arts training, the incidence of ankle joint injuries is relatively high. In order to prevent and reduce ankle joint injuries, high-intensity martial arts training should be used to evaluate the degree of ankle joint injuries in a timely manner using an ankle joint injury assessment model. Secondly, a Firefly algorithm based modeling method for the evaluation of ankle injury in high-intensity martial arts training is proposed. Finally, 180 questionnaires were distributed and 150 were collected. Three incomplete questions were removed, resulting in 130 valid questions with a yield of 90. The firefly algorithm has been used to assess ankle injuries and to characterize different types of combat shooting in high-intensity exercise competitions. received ankle injury index assessment combat performance. A chaotic sequence is used to fire and established a standard measurement of effort for combat ankle injuries. The proposed solution has been scientifically proven to improve basketball performance levels.</div></div>","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100213"},"PeriodicalIF":2.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of m6A-related lncRNAs prognostic signature for predicting immunotherapy response in cervical cancer 鉴定用于预测宫颈癌免疫疗法反应的 m6A 相关 lncRNAs 预后特征
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-10-28 DOI: 10.1016/j.slast.2024.100210
Quanhong Ping , Qi Chen , Na Li
{"title":"Identification of m6A-related lncRNAs prognostic signature for predicting immunotherapy response in cervical cancer","authors":"Quanhong Ping ,&nbsp;Qi Chen ,&nbsp;Na Li","doi":"10.1016/j.slast.2024.100210","DOIUrl":"10.1016/j.slast.2024.100210","url":null,"abstract":"<div><h3>Background</h3><div><em>N</em>6-methylandenosine-related long non-coding RNAs (m<sup>6</sup>A-related lncRNAs) play a crucial role in the cancer progression and immunotherapeutic efficacy. The potential function of m<sup>6</sup>A-related lncRNAs signature in cervical cancer has not been systematically clarified.</div></div><div><h3>Methods</h3><div>RNA-seq and the clinical data of cervical cancer were extracted from The Cancer Genome Atlas. All of the patients were randomly classified into training and testing cohorts. The m<sup>6</sup>A-related lncRNAs prognostic model was constructed by LASSO regression using data in the training cohort.The predictive value of the signature was validated in the whole cohort and testing cohort. Cervical cancer patients were divided into low- and high-risk subgroups by the median value of risk scores. Kaplan-Meier analysis, principal-component analysis (PCA), functional enrichment annotation, and nomogram were used for further evaluation. We also examined the immune response and potential drug sensitivity targeting this model.</div></div><div><h3>Results</h3><div>Seventy-nine prognostic m<sup>6</sup>A-related lncRNAs were screened. The risk model comprising four m<sup>6</sup>A-related lncRNAs (AL139035.1, AC015922.2, AC073529.1, AC008124.1) was identified and verified as an independent prognostic predictor of cervical cancer. A nomogram based on age, tumor grade, clinical stage, TNM stage, and four m<sup>6</sup>A-related lncRNAs risk signatures was generated. It displayed good accuracy and reliability in predicting the overall survival of patients with CC. Based on our risk model, cervical cancer patients with potential immunotherapy benefits from the candidate drugs could be effectively screened.</div></div><div><h3>Conclusion</h3><div>The four m<sup>6</sup>A-related lncRNAs signature may provide new targets and allow the prediction of immunotherapy response, which can assist developing individualized treatment for cervical cancer.</div></div>","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100210"},"PeriodicalIF":2.5,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142552829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regional developers’ community accelerates laboratory automation 地区开发者社区加速实验室自动化。
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-10-24 DOI: 10.1016/j.slast.2024.100211
Akari Kato , Takaaki Horinouchi , Haruka Ozaki , Genki N. Kanda
{"title":"Regional developers’ community accelerates laboratory automation","authors":"Akari Kato ,&nbsp;Takaaki Horinouchi ,&nbsp;Haruka Ozaki ,&nbsp;Genki N. Kanda","doi":"10.1016/j.slast.2024.100211","DOIUrl":"10.1016/j.slast.2024.100211","url":null,"abstract":"","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100211"},"PeriodicalIF":2.5,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering the role of heat shock protein HSPA1L: biomarker discovery and prognostic insights in Parkinson's disease and glioma 解读热休克蛋白 HSPA1L 的作用:发现帕金森病和胶质瘤的生物标志物并深入了解其预后。
IF 2.5 4区 医学
SLAS Technology Pub Date : 2024-10-23 DOI: 10.1016/j.slast.2024.100212
Hong Cheng , Jing Wang , Yingjie Zhao , Xiaoli Hou , Fang Ling , Yixia Wang , Yasen Cao
{"title":"Deciphering the role of heat shock protein HSPA1L: biomarker discovery and prognostic insights in Parkinson's disease and glioma","authors":"Hong Cheng ,&nbsp;Jing Wang ,&nbsp;Yingjie Zhao ,&nbsp;Xiaoli Hou ,&nbsp;Fang Ling ,&nbsp;Yixia Wang ,&nbsp;Yasen Cao","doi":"10.1016/j.slast.2024.100212","DOIUrl":"10.1016/j.slast.2024.100212","url":null,"abstract":"<div><h3>Background</h3><div>Heat shock proteins (HSPs) play a critical role in cellular stress responses and have been implicated in numerous diseases, including Parkinson's disease (PD) and various cancers. Understanding the differential expression and functional implications of HSPs in these conditions is crucial for identifying potential therapeutic targets and biomarkers for diagnosis and prognosis.</div></div><div><h3>Methods</h3><div>We utilized combined datasets (GSE6613 and GSE72267) to identify and analyze the heat shock-related genes differentially expressed in PD. Gene Set Variation Analysis (GSVA) was performed to explore functional profiles, while LASSO regression was employed to screen potential PD biomarkers. In glioma, prognostic value, immune infiltration, and pathway enrichment associated with HSPA1L gene expression were assessed via Kaplan-Meier plots, ssGSEA, and enrichment analyses.</div></div><div><h3>Results</h3><div>In PD, we identified 17 differentially expressed HSPs. Enrichment analysis revealed significant pathways related to protein homeostasis and cellular stress responses. LASSO regression pinpointed 12 genes, including HSPA1L, as significant markers for PD, with nomogram and calibration plots indicating predictive accuracy. Stratification based on HSPA1L expression in PD highlighted differentially active biological processes, immune responses, and metabolic disruptions. In the pan-cancer analysis, HSPA1L showed variable expression across cancer types and a significant correlation with patient survival and immune infiltration. In glioma, low HSPA1L expression was associated with worse overall survival, distinct immune infiltration patterns, and altered pathway activities.</div></div><div><h3>Conclusion</h3><div>This integrative study reveals the substantial role of HSPs, especially HSPA1L, in the pathogenesis and prognosis of PD and glioma. Our findings offer new perspectives on the molecular mechanisms underlying these diseases and propose HSPA1L as a potential prognostic biomarker and a target for therapeutic intervention.</div></div>","PeriodicalId":54248,"journal":{"name":"SLAS Technology","volume":"29 6","pages":"Article 100212"},"PeriodicalIF":2.5,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信